Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A rare malignant heterologous neoplasm with skeletal muscle differentiation arising from the uterine corpus. It usually manifests with vaginal bleeding. The prognosis is poor.
No clinical trials have been registered for uterine corpus rhabdomyosarcoma.
5 publications have been identified in PubMed for uterine corpus rhabdomyosarcoma. Research spans Case Report / Case Series (60%) and Review / Meta-Analysis (40%).
Pilkington T (2026). [PMID: 41369044](https://pubmed.ncbi.nlm.nih.gov/41369044/). *The American journal of surgical pathology*. [Case Report / Case Series]
Omuro M (2025). [PMID: 41169952](https://pubmed.ncbi.nlm.nih.gov/41169952/). *Gynecologic oncology reports*. [Review / Meta-Analysis]
Odai T (2024). [PMID: 38707732](https://pubmed.ncbi.nlm.nih.gov/38707732/). *Cancer diagnosis & prognosis*. [Case Report / Case Series]
Dashti NK (2024). [PMID: 39127354](https://pubmed.ncbi.nlm.nih.gov/39127354/). *Human pathology*. [Case Report / Case Series]
Kamel NKH (2024). [PMID: 39020398](https://pubmed.ncbi.nlm.nih.gov/39020398/). *Diagnostic pathology*. [Review / Meta-Analysis]
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 9:41 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center